Asthma :: Does birth order affect asthma risk?
A recent study challenges an old theory known as the ?hygiene hypothesis,? which suggests that older children protect their younger siblings from developing asthma.
A recent study challenges an old theory known as the ?hygiene hypothesis,? which suggests that older children protect their younger siblings from developing asthma.
New research indicates that children who receive antibiotics before their first birthday are significantly more likely to develop asthma by age 7. The study, published in the June issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), reports that children receiving antibiotics in the first year of life were at greater risk for developing asthma by age 7 than those not receiving antibiotics.
Dey, L.P. announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) of its marketing partner, Critical Therapeutics, Inc. (Nasdaq: CRTX), for ZYFLO CR? (zileuton) extended-release tablets.
A survey of 1,812 patients with moderate-to-severe asthma revealed that the disease was not controlled in 55 percent, despite the fact that most had health insurance and visited their health care providers regularly.
After analyzing results of a survey of more than 3,000 adults with asthma, researchers at Emory Crawford Long Hospital have found that obese patients with asthma are more likely to have severe asthma when compared to those who are not overweight.
Asthmatx, Inc., a medical device company that has developed a catheter-based procedure for the treatment of asthma, announced today that positive results from the Research in Severe Asthma (RISA) Trial were reported today at the annual scientific assembly of the American Thoracic Society (ATS) by Neil Thomson, MD, Professor of Respiratory Medicine, University of Glasgow, Glasgow, Scotland.
Some children may not be able to keep their asthma under control even if they consistently report using inhaled corticosteroids, a mainstay of asthma treatment, suggests a new study presented at the American Thoracic Society 2007 International Conference, on Wednesday, May 23.
A new study presented at the American Thoracic Society 2007 International Conference finds that obese people are significantly more likely to have persistent or severe persistent asthma than their thinner counterparts.
New data demonstrated that the combination asthma therapy, SYMBICORT? (budesonide/formoterol fumarate dihydrate), led to significant improvements in health-related quality of life (HRQL) and greater patient-reported satisfaction with asthma treatment, versus its monocomponents (budesonide or formoterol) or placebo.
Asthmatx, Inc., a medical device company that has developed a catheter-based procedure for the treatment of asthma, announced today the successful completion of enrollment in its pivotal FDA approved IDE study, the Asthma Intervention Research 2 (AIR2) Trial of the Alair? Bronchial Thermoplasty System. Bronchial Thermoplasty is a non-drug treatment for asthma under clinical investigation in the United States.